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Abbreviations 
DCs – Dendritic Cells 
CTRs - C-type lectin receptors 
FhTeg – Fasciola hepatica Tegumental Antigens 
MAPK - Mitogen-activated protein kinases 
NK-kB - Nuclear factor kappa B 
SOCS3 - Suppressor of cytokine signalling (SOCS) 3 
STAT3 - signal transducers and activators of transcription3 
TLR – Toll-like receptor 
TRIL - TLR4 interactor with leucine-rich repeats 
VTCN-1 - V-set domain-containing T cell activation inhibitor-1 
WHO – World Health Organisation 
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ABSTRACT 
Fasciola hepatica, commonly known as liver fluke, is a trematode which causes Fasciolosis 
in ruminants and humans. The outer tegumental coat of F. hepatica (FhTeg) is a complex 
metabolically active biological matrix that is continually exposed to the host immune system 
and therefore makes a good vaccine target. F. hepatica tegumental coat is highly glycosylated 
and helminth-derived immunogenic oligosaccharide motifs and glycoproteins are currently 
being investigated as novel vaccine candidates. This report presents the first systematic 
characterisation of FhTeg glycosylation using lectin microarrays to characterise 
carbohydrates motifs present, and lectin histochemistry to localize these on the F. hepatica 
tegument. We discovered that FhTeg glycoproteins are predominantly oligomannose 
oligosaccharides that are expressed on the spines, suckers and tegumental coat of F. hepatica 
and lectin blot analysis confirmed the abundance of N- glycosylated proteins. While some 
oligosaccharides are widely distributed on the fluke surface other subsets are restricted to 
distinct anatomical regions. We selectively enriched for FhTeg mannosylated glycoprotein 
subsets using lectin affinity chromatography and identified 369 proteins by mass 
spectrometric analysis. Among these proteins are a number of potential vaccine candidates 
with known immune modulatory properties including proteases, protease inhibitors, 
paramyosin, Venom Allergen-like II, Enolase and two proteins, nardilysin and TRIL, that 
have not been previously associated with F. hepatica. Furthermore, we provide a 
comprehensive insight regarding the putative glycosylation of FhTeg components which 
could highlight the importance of further studies examining glycoconjugates in host-parasite 
interactions in the context of F. hepatica infection and the development of an effective 
vaccine.   
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INTRODUCTION 
Fasciola hepatica is a parasitic flatworm of livestock and the causative agent of Fasciolosis, a 
disease that results in major economic losses to the agricultural industry globally, estimated at 
$3 billion annually (1). Fasciolosis has recently been acknowledged by the World Health 
Organization (WHO) as a neglected tropical zoonotic disease, with as many as 2 to 17 million 
people infected worldwide and 180 million at risk of infection (2). Infection in animals is 
currently treated chemically with drugs such as triclabendazole, albendazole and 
oxyclosanide, although drug-resistance is now widespread across Europe and globally (3). 
While vaccines are considered a safe, economically viable and environmentally friendly 
solution none have been commercially developed to date and there is a dearth of promising 
candidates with potent immunoprotective efficacy in the pipeline (4). 
 
It is only recently that the fluke surface tegument has been the subject of close investigations 
by molecular techniques (4,5,6,7) with the aim of discovering novel potential targets for both 
drug and vaccine development. The F. hepatica tegument is a metabolically active layer that 
is continuously sloughed off and replaced during infection. The tegument is intimately 
associated with host tissues and performs a number of important functions including the 
synthesis and secretion of substances, absorption of nutrients, osmoregulation and protection 
against host enzymes (8). Closely packed spines that point posteriorly are distributed 
throughout the tegument and help maintain the position of the fluke within the tissues and 
bile duct. The spines also facilitate feeding of the obligate blood-feeding adult through the 
erosion of the epithelium and puncturing of small bloods vessels (8). It is highly likely that 
the shed tegumental coat is released into the blood stream and studies have shown the 
presence of anti-tegumental antibodies in serum form infected animals (9).  
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The outer-most surface of the tegument is shielded by a glycocalyx that is comprised 
predominantly of glycoconjugates (10). Glycoproteins and glycolipids of parasitic helminths 
often contain a mixture of oligosaccharide motifs similar or identical to those present in their 
hosts, as well as structurally-unusual, pathogen-specific motifs (11). These glycoconjugates 
can play key roles in the immunoregulatory activity of the parasite by interacting with C-type 
lectin receptors (CLRs) (12). We have previously shown that a preparation of tegumental 
antigen (FhTeg) exhibits potent Th1 immune suppressive properties in vivo by reducing 
serum levels of IFNγ and IL-12p70 in the mouse model of septic shock (13). FhTeg-activated 
dendritic cells and mast cells are hypo-responsive to Toll-like Receptors (TLR) activation and 
thereby suppress the production of inflammatory cytokines and co-stimulatory molecules 
important in driving adaptive immune responses (14). The FhTeg mechanism of action is 
independent of TLRs and has been linked to the suppression of NF-κB and MAPK pathways 
and enhanced expression levels of suppressor of cytokine signalling (SOCS) 3, a negative 
regulator of the TLR and STAT3 pathways that is observed in vitro and following F. hepatica 
infection (15, 16).  
   
The contribution of glycoconjugates to the development of protective immunity to Fasciola 
infection has yet to be established and, even if these oligosaccharides are not antigenic per se, 
they can influence the immunogenicity of glycoprotein-based vaccines by contributing to 
correct protein folding and biophysical properties (17), as well as to the modulation of 
antigen processing and activation of antigen presenting cells. One of the first steps of 
understanding the role of Fasciola glycoconjugates is to identify the glycoproteins on its 
tegumental coat. Here we employed orthogonal lectin assays to probe the F. hepatica 
tegumental components and profile the variety of glycoprotein and carbohydrate moieties at 
or close to the parasite surface. Selective enrichment of these tegumental glycoproteins was 
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performed using lectin chromatography and these were subjected to proteomic analysis. This 
study provides a comprehensive and novel insight regarding glycoprotein composition of the 
FhTeg and has identified those that likely play critical functions at the interface between 
parasite and host.  
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MATERIAL AND METHODS 
Antigen preparation 
F. hepatica tegumental extract (FhTeg) was prepared as previously reported (13). In brief, F. 
hepatica adult worms following collection from sheep at an abattoir in Ireland were washed 
in sterile phosphate-buffered saline (PBS) and incubated in 1% Nonidet P-40 (NP-40 [Sigma 
Aldrich, Ireland] in PBS) for 30 min. Supernatant was collected and NP-40 removed using 
detergent-removing biobeads (Bio-Rad laboratories, Fannin Ltd, Ireland), and the remaining 
supernatant was centrifuged at 14,000 × g for 30 min at 4°C prior to being 
filtered/concentrated using compressed air, and then stored at −20°C. All protein 
concentrations were determined using a bicinchoninic acid protein assay kit (Promeaga, 
Madison, USA).  
 
Profiling of FhTeg oligosaccharides by lectin microarray 
FhTeg was fluorescently labelled with Alexa Fluor 555 via carboxylic acid succinimidyl ester 
conjugation strategy according to manufacturer instructions (ThermoFischer Scientific. MSc 
Co ltd, Ireland). Excess dye was removed from FhTeg-555 using a desalting column (7 kDa 
molecular weight cut off (MWCO) [Invitrogen, Paisley, UK]). Final protein concentration 
and labelling efficiency was calculated according to the manufacturer’s instructions by 
measuring sample absorbance at 280 and 550 nm and using the arbitrary values for molecular 
mass (100,000) and extinction coefficient (E of 10). 
 
A panel of 48 lectins (Table S1) was printed on Nexterion® Slide H microarray slides in a 
62% (±2%) humidity environment using a SciFLEXARRAYER S3 (Scienion AG, Germany) 
equipped with a 90 µm uncoated glass dispenser capillary to construct the lectin microarray 
as previously described (18). Microarray incubations were carried out essentially as 
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previously described (18) and all procedures were carried out in the dark. In brief, FhTeg-555 
was diluted in Tris-buffered saline supplemented with Ca2+ and Mg2+ ions (TBS; 20 mM Tris-
HCl, 100 mM NaCl, 1 mM CaCl2, 1 mM MgCl2, pH 7.2) and with 0.05% Tween 20 (TBS-T) 
for incubation on the microarrays using an 8 well gasket (Agilent Technologies, Cork, 
Ireland) at room temperature for 1 h with gentle rotation (4 rpm) in the dark. Initially several 
concentrations (2.9-14.4 μg/ml) were titrated to determine the best concentration for optimal 
signal to noise ratio. Based on the binding interactions observed from the titration 
experiments, samples were also co-incubated with 100 mM Gal and Man in parallel on the 
lectin microarrays to verify carbohydrate-mediated binding (19). Incubations were carried out 
in triplicate using the optimal concentration of 8.6 μg/ml FhTeg in TBS-T. After incubation, 
the microarray slides were disassembled under TBS-T, washed three times in TBS-T for 2 
min each with gentle agitation in a Coplin jar, with a final 2 min wash in TBS. The slides 
were centrifuged until dry and scanned immediately with the 532 nm laser (90% laser power, 
5 µm resolution) of an Agilent G2505B microarray scanner. Three replicate experiments were 
performed.  
 
Microarray data extraction was performed as previously described (18). In brief, raw intensity 
values were extracted from the image files using GenePix Pro v6.1.0.4 (Molecular Devices) 
and a proprietary address file (*.gal) using adaptive diameter (70–130%) circular alignment 
based on 230 μm features and exported as text to Excel (version 2007, Microsoft). Local 
background-corrected median feature intensity data (F543median-B543) was selected and the 
median of six replicate spots per subarray was handled as a single data point for graphical and 
statistical analysis. Data were normalized to the mean of three replicate microarray slides 
(subarray by subarray using subarray total intensity), and binding data was presented in 
histogram form of mean intensity with one standard deviation of three experimental replicates 
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(n = 3, 18 data points in total). Unsupervised clustering of normalized lectin binding data was 
performed with Hierarchical Clustering Explorer v3.5 (HCE 3.5; Human–Computer 
Interaction Lab, University of Maryland, http://www.cs.umd.edu/hcil/hce/hce3.html). Mean 
normalized data was initially clustered with the following parameters: no pre-filtering, 
complete linkage and Euclidean distance. 
 
SDS-PAGE, Lectin and Western blot analysis of FhTeg. 
Precast 10% sodium dodecyl sulphate (SDS)-polyacrylamide gels (Pierce) were run under 
standard reducing conditions. Samples were loaded at a concentration of 10 µg/ml and gels 
were subjected to Coomassie or silver staining (20), or transferred onto nitrocellulose 
membranes by iBlot Dry blotting system (Thermo Fisher Scientific, Ireland) for western 
analysis. After standard western blotting procedures with primary (goat anti-biotin antibody 
and biotinylated lectins as per manufacturer’s instructions (Vector Laboratories Ltd, Uk) and 
secondary antibody (IRDye 800 Streptavidin and IRDye 680 anti-goat; Li-COR Biosciences, 
Nebraska USA), the membranes were scanned using Odyssey Infrared Imaging System (Li-
COR Biosciences). Data analysis was performed with Odyssey V 3.0 software (Li-COR 
Biosciences). 
 
Lectin- and immuno-fluorescence microscopy of parasite surface oligosaccharides 
Adult liver flukes were flat-fixed in 4% paraformaldehyde and incubated with fluorescein-
labelled lectins or with biotin-MAL II followed by incubation with fluorescein-labelled anti-
biotin (Vector Laboratories, Peterborough, United Kingdom). Parasites were mounted on 
glass microscope slides with Vectashield® anti-fading solution with or without DAPI (Vector 
Laboratories). Specimens were viewed using a Leica DM IL LED microscope using 10x, 
20x, and 40x HI PLAN I objectives (Leica Microsystems, Ashbourne, Ireland) equipped with 
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epifluorescent source and a filter system for FITC and TRITC fluorescence. Images were 
processed with Adobe Photoshop CS4 software (Adobe System Inc.). 
 
Selective biotinylation and isolation of FhTeg glycoproteins 
FhTeg glycoproteins (Glyco-FhTeg) were isolated by biotinylating the carbohydrates with 
carbohydrate-specific EZ-link hydrazide-biotin (Thermo Fisher Scientific, Ireland) according 
to manufacturer guidelines (see Supplemental Figure 1A). Western blot analysis with IR-
labelled streptavidin complex confirmed the efficient biotinylation of the FhTeg 
glycoproteins (FhTeg-B; Supplemental Figure 1B). FhTeg-B was purified using the 
biotin/avidin system using a monomeric avidin-agarose column (Thermo Scientific, Pierce, 
Ireland). Non-biotinylated (non-glycosylated) proteins flowed through the column 
constituting the Avidin FT fraction, while biotinylated (glycosylated) proteins (Avidin B) 
were displaced from avidin-immobilised beads by elution with concentrated biotin in 
reducing conditions. This purified biotinylated glycoprotein fraction is referred to as Glyco-
FhTeg. Western blot analysis (Supplemental Figure 1C) confirmed the presence of 
biotinylated molecules in the starting material (FhTeg-B), bound fraction (FhTeg-B Avidin B) 
but not in the flow through material (FhTeg-B Avidin FT).  
  
Isolation of mannose-rich glycoproteins by lectin affinity chromatography 
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Mannose-rich glycoprotein components of the FhTeg were obtained by lectin affinity 
chromatography using plant lectins ConA, LCA and GNL. FhTeg was buffer exchanged in 
lectin binding buffer (20 mM Tris-HCl, 0.15 M NaCl, 1 mM CaCl2, 1 mM MnCl2, pH 7.2) 
using 7 kDa MWCO Zeba spin columns (Thermo Fisher Scientific, Ireland) and then 
incubated with ConA-, LCA-, or GNL-agarose slurry (Vector Laboratories ltd, UK) with end-
over-end agitation overnight at 4 ºC. The beads were centrifuged and the unbound fractions 
decanted. Following extensive washing, the beads were incubated for 3 h at room 
temperature with 2 column volumes of inhibiting sugars to elute bound oligosaccharides (0.5 
M alpha-methylmannoside and 0.5 M alpha-methylglucoside for ConA; 0.5 M 
methylmannoside for GNL and LCA). High concentrations of salts and monosaccharides 
were removed from both unbound and bound fractions by diafiltration in Amicon Ultra 
centrifugal filters with 3 kDa MWCO (Millipore Ireland B.V., Cork, Ireland). Isolation yields 
and efficiency were monitored by measuring total protein content of fractions with BCA 
assay, SDS-PAGE and lectin blot probed with ConA, LCA, and GNL (Supplemental Figure 
1), as described above, before subjecting these to proteomic analysis. The combined 
proteome of the three lectin affinity purified fractions (ConA, LCA, and GNL) is referred to 
Man-FhTeg. 
 
Experimental Design and Statistical Rationale 
Microarray, lectin blots and micrographs were performed with at least two 
biological replicates. For the proteomics study, whole Fasciola tegument was 
initially analyzed by LC-MS/MS. Since the aim of this experiment was to profile 
the molecules associated with fluke tegument, no biological replicates were used 
and therefore no quantitation was performed. 
 
Fasciola hepatica tegumental glycoproteins 
 
12 
 
Mass spectrometry analysis of FhTeg lectin-purified fractions 
Selected F. hepatica fractions were subjected to proteomics analysis by mass spectrometry 
(MS by Proteomique Platform of the Quebec Genomics Center, CHU de Quebec Research 
Centre, Quebec, Canada). Liquid chromatography/tandem mass spectrometry (LC-MS/MS) 
was carried out according to a previously reported protocol (21). Briefly, proteins were 
resolved by SDS-PAGE, the gel was stained with SYPRO Ruby gel stain according to the 
manufacturer’s instructions (Bio-Rad Laboratories, Fannin Ltd, Ireland). The protein bands 
were cut into gel slices and deposited in 96-well plates. A liquid handling station (MassPrep; 
Waters) was used, with sequencing-grade modified trypsin (Promega, Madison USA) for in-
gel protein digestion according to the manufacturer’s instructions. Peptide extracts were then 
dried by evaporation in a SpeedVac (Thermo Fisher Scientific, Ireland). LC-MS/MS 
experiments were performed with an TripleTOF 5600  mass spectrometer connected to a 
Thermo Surveyor MS pump and equipped with a nanoelectrospray ion source (all from 
Thermo Fisher Scientific, Ireland). The peptides were separated in a PicoFrit BioBasic C18 
column (0.075 mm I.D. x 10 cm; New Objective), with a linear gradient from 2 to 50% 
solvent B (acetonitrile, 0.1% formic acid) over 30 min at a flow rate of 200 nl/min. Mass 
spectra were acquired in the data-dependent acquisition mode (Xcalibur software, version 
2.0). Each full-scan mass spectrum (m/z 400–2,000) was followed by the collision-induced 
dissociation of the seven ions giving the most intense signals. The dynamic exclusion 
function was enabled (30 s of exclusion), and the relative collisional fragmentation energy 
was set at 35%. Peak list files were generated by Protein Pilot v5.0 (Sciex) using default 
parameters and exported to Mascot v2.4.1 (Matrix Science) for database searching. 
 
Database searching 
All MS/MS spectra were analysed with Mascot (version 2.4.1; Matrix Science), set up to 
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search against a database comprised of gene models identified from the recently sequenced F. 
hepatica draft genome (version 1.0, 101,780 entries; 22) and the Uniprot sheep protein 
databank (27174 entries), assuming digestion with trypsin with 2 missed cleavages permitted. 
A subset of this database was used for the tandem spectra also assuming trypsin. The F. 
hepatica gene model sequences can be accessed through WormBase ParaSite 
(http://parasite.wormbase.org/) under accession PRJEB6687 (genomic read data and 
gene model transcripts). Fragment and parent ion mass tolerance were set at 0.100 Da. 
Carbamidomethylation of cysteine was as a fixed modification and the dehydration of the N-
terminus, Glu->pyro-Glu of the N-terminus, ammonia-loss of the N-terminus, Gln->pyro-Glu 
of the N-terminus, deamidation of asparagine and glutamine, oxidation of methionine, hex of 
arginine and threonine and biotin of lysine were specified as variable modifications.   
 
Criteria for protein identification 
Scaffold (version 4.3.4, Proteome Software Inc., Portland, OR) was used to validate MS/MS 
based peptide and protein identifications. Peptide identifications were accepted if they could 
be established at greater than 95% probability to achieve an FDR less than 1.0% by the 
Peptide Prophet algorithm (24) with Scaffold delta-mass correction. Protein identifications 
were accepted if they could be established at greater than 95.0% probability to achieve an 
FDR less than 1.0% and contained at least 2 identified peptides. Protein probabilities were 
assigned by the Protein Prophet algorithm (24). Proteins that contained similar peptides and 
could not be differentiated based on MS/MS analysis alone were grouped to satisfy the 
principles of parsimony. Putative annotation of the F. hepatica gene models was assigned 
using in silico tools, Uniprot, Gene Ontology (GO) and InterproScan (20). The identified 
proteins in this study were categorised according to their GO classification. Glycosylation 
predictive analysis was carried out using NetNGlyc 1.0 and NetOGlyc 4.0 Servers (25).  
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RESULTS 
Lectin microarray profiling of the F. hepatica tegument demonstrates characteristic 
glycoprotein content 
The glycosylation of FhTeg was characterised on a lectin microarray featuring a 
comprehensive panel of plant, bacterial and fungal lectins (Figure 1A and supplemental Table 
1). FhTeg exhibited a particularly high affinity for the Man-binding lectins (Calsepa, NPA, 
GNA, HHA and Con A; Supplemental Table 1), which suggested a predominance of 
glycoproteins modified with oligomannose type N-linked oligosaccharide structures at the 
parasite surface. Binding to LEL and DSA indicated the presence of N-acetylglucosamine 
(GlcNAc) residues, but these residues were likely predominantly part of the chitobiose core 
(GlcNAc-β-(1,4)-GlcNAc) of N-linked structures and/or N-acetyllactosamine (Gal-β-(1,4)-
GlcNAc) in the antennae rather than terminal GlcNAc residues as other typical GlcNAc-
binding lectins such as GSL-II displayed only moderate binding. FhTeg also bound to the 
fucose-binding lectins AAL, LTA and UEA-I and to the terminal α-linked galactose-(Gal-) 
binding lectins GSL-I-B4, MPA, VRA and MOA. The presence of complex-type N-linked 
oligosaccharides was also confirmed by binding to PHA-L and –E and CPA (Figure 1A). 
Structures with terminal β-linked Gal and residues were inferred to be relatively abundant 
due to moderate binding intensity with the lectins RCA-I, AIA, PNA and PHA-E with N-
acetylgalactosamine (GalNAc) residues further indicated by more intense binding with SNA-
II (Supplemental Table 1). Additionally, the binding of AIA and PNA may further indicate the 
presence of O-linked oligosaccharides in FhTeg protein extract, more specifically the T 
antigen (Gal-β-(1,3)-GalNAc-O-Ser/Thr), and PNA binding suggested that these structures 
were not sialylated (Supplemental Table 1). Interestingly, only low binding was observed for 
lectins with binding affinities for sialic acid-containing moieties, SNA-I, MAA and WGA, 
except for CCA which recognises 9-O-acetyl- and 4-O-acetylneuraminic acids (26) and 
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bound intensely with FhTeg (Figure 1A). Only minor differences were observed between 
three separate analyses of the FhTeg (Figure 1B). 
 
Oligosaccharide motifs are localised mainly at the spines and suckers of adult flukes 
and are present on a wide panel of glycoproteins.  
To determine the localization of lectin-binding motifs on the superficial aspects of the 
tegumental coat, flat fixed adult flukes were incubated with a panel of fluorescein-conjugated 
lectins selected on the basis of the above microarray data. While all lectins yielded 
remarkable visualization of the external morphological features of the adult fluke such as oral 
and ventral suckers, tegumental spines and tegumental coat, differences were observed in the 
binding patterns between lectins. Table 2 summarises the micrograph observations based on 
the anatomical region visualised and the intensity of fluorescence.  
 
All Man-binding - and terminal GlcNAc-binding lectins shared a strong binding to fluke 
spines, sucker and tegumental coat (Figure 2A; 3A). Similarly, all GalNAc-binding lectins 
bound to these anatomical features, with strong binding being observed for SBA and GSL-I 
compared with weaker binding for VVL and DBA.  AAL, which recognises predominantly α-
(1,3) and α(1,6)-linked Fuc core modifications, predominantly bound to the tegumental 
spines, compared with UEA-I, which was predominantly observed at the surface edges of the 
fluke’s coat, suggesting a widespread but low expression of the α(1-2)-linked Fuc moieties 
recognised by UEA-I. The complex-type N-linked oligosaccharides that were selectively 
bound by PHA-E and PHA-L were only observed at the edge of the sucker areas. Binding 
with affinity for α(2-3)-linked sialic acids (MAA) and Gal (PNA and ECL) were primarily 
observed on the spines and spinelets.  
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The same panel of lectins was also used to probe blots of denatured FhTeg protein extracts 
(Figures 2-4). ConA bound to multiple glycoproteins and bound to the greatest number of 
glycoproteins of all the lectins examined and the greatest Mr range (Figure 2A). LCA and 
PSA that bind to oligomannose oligosaccharides and GNL that recognises structures 
containing α(1-3)linked Man residues, bound to proteins of similar Mr but to a lower number 
of proteins. Differences were also observed for the Fuc-binding lectins; AAL bound intensely 
to a small number of glycoprotein bands at approximately 20-25, 32, 37-47 kDa, compared 
with a wider Mr range of protein bands weakly bound  by UEA-I. PHA-E and PHA-L, bound 
to four main protein bands at approximately 10, 22, 38 and 48 kDa, with some additional 
minor bands between 10 to 75 kDa (Figure 2C).  
 
By contrast, only two prominent protein bands, at approximately 150 and 200 kDa (Figure 
3A), were detected by Jacalin and GSL-II. GSL-II binds to GlcNAc residues while Jacalin 
can bind to terminal β-linked Gal (which can be present on N-linked structures as well as O-
linked). Jacalin has the greatest affinity for T antigen, but does not conclusively prove its 
presence while Jacalin may indicate the presence of O-linked structures, in agreement with 
the PNA and AIA binding observed on the lectin microarray, both of which bind only O-
glycosidically linked oligosaccharides (Figure 3A).  No proteins were detected by WGA 
(recognises GlcNAc and Neu5Ac motifs) and sWGA (recognises GlcNAc motifs) which 
suggest that the structures histochemically recognised by these lectins could be present on 
glycolipids. All GalNAc-binding lectins detected a similar Mr range by lectin blots, with 
dominant binding to protein bands observed at 10, 22 and 37 kDa (Figure 3B). VVL and 
DBA bind to proteins between the Mr range of 50 to100 kDa.  
 
MAL II-binding motifs were present on a number of glycoproteins at approximately 10, 17, 
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22, 40, 75kDa and >250 kDa (Figure 4A). Similarly MAL-I motifs were found at this Mr, 
supporting the possible presence of α(2-3)-linked sialic acid. SNA-I that recognises α(2-6)-
linked sialic acid bound to proteins at an Mr range between 20 to 75 kDa (Figure 4A). The 
binding to MAL I and SNA motifs suggests that both terminal and non-terminal sialylated 
oligosaccharides are present. The abundance of LacNAc was confirmed by the strong binding 
observed for all the Gal-binding lectins used in this study (PNA, RCA-I and ECL; Figure 
4B). Terminal ß-linked Gal, including the residue in LacNAcis a common feature on the 
antennae of complex and hybrid N-linked mammalian-oligosaccharides, as well as on O-
linked oligosaccharides. PNA and ECL both bound to single bands at approximately 10 and 
22 kDa and a number of protein bands at approximately 37 kDa. Fewer protein bands were 
detected by RCA-I at 50 and between 150-250 kDa (Figure 4B).  
 
Proteomic analysis FhTeg glycosylated and mannosylated protein subsets.  
A total of 369 proteins were identified by proteomic analysis of FhTeg and two sub-fractions 
isolated using biotinylation of the tegument, Glyco-FhTeg, and mannose-lectin affinity 
chromatography, Man-FhTeg. Interestingly, despite Glyco-FhTeg and Man-FhTeg being 
glycoprotein subsets of FhTeg, during parallel analysis more proteins were identified in these 
fractions (n=141 and 341, respectively) than in FhTeg (n=65) (Figure 5A). We believe that 
elimination of major non-glycosylated proteins from the FhTeg by the enrichment of specific 
subsets by affinity chromatography enabled the identification of broader profile of 
glycoproteins. Analysis of the F. hepatica tegumental proteins against the Uniprot sheep 
protein databank, resulted in 28 protein identifications, with the majority of the proteins 
identified enriched within the FhManTeg sample.  These proteins were associated with the 
host blood and immune systems, including serum albumin, haemoglobin, hemopexin, IgM, 
IgJ and alpha 2 macroglobulin.  The full lists of proteins identified are reported in 
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Supplemental Tables 3-4 Not surprisingly, however, the vast majority the proteins identified 
in FhTeg were shared with the Glyco-FhTeg and Man-FhTeg preparations, confirming the 
high level of glycosylation of F. hepatica tegumental proteins. Dynein 8 kDa light chain outer 
arm and glutathione S-transferase mu class 27 were the only two protein hits unique to 
FhTeg. Comparative analysis of the 141 biotinylated glycoproteins (Glyco-FhTeg) with the 
341 mannosylated glycoproteins (Man-FhTeg) revealed that 26 glycoproteins were unique to 
the Glyco-FhTeg preparation (Table 3) and that these comprised of mainly  glycoproteins 
important for protein synthesis and structure and a number of catalytic enzymes  
 
The abundance of mannosylated glycoproteins revealed by our lectin array and lectin blot 
analysis was supported by the high number of proteins identified by proteomic analysis of 
Man-FhTeg. A total of 341 proteins were identified based on at least two unique peptides 
using ConA-, LCA-, or GNL-lectin affinity purified fractions (209, 185, or 301, respectively). 
As expected, the three Man-binding lectins isolated similar subsets of glycoproteins (222 
shared hits; 65%), though a number of glycoproteins were unique to each subset (Figure 5B). 
Although each lectin did not show any enrichment for a particular type of protein, several 
important Fasciola proteins were found uniquely in one or other fraction. For example, 
cathepsin L and cathepsin B cysteine proteases were identified in the ConA fraction, an 
asparaginyl endopeptidase (legumain) in the LCA fraction and a zeta class gluthatione S-
transferase (GST) in the GNL fraction (Supplemental Table 5).   
 
To define the most abundant glycoproteins in the parasite tegument, the 50 most represented 
proteins in each of the ConA-, LCA-, or GNL-lectin affinity purified fractions was compiled, 
based on the number of unique peptides, and resulted in a total of 74 glycoproteins; these 
were then categorised according to their GO classifications (Table 4, supplemental tables 5-7. 
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Twenty eight glycoproteins were identified as being particularly abundant in all three 
mannose-rich glycoprotein preparations, which included structural proteins, metabolic 
enzymes, heat shock proteins and cysteine proteases.  Of the remaining 46 glycoproteins, 31 
glycoproteins were only identified in one of the three preparations, indicating that these 
proteins exhibit lectin-specific glycoforms.  Although not particularly abundant, a number of 
proteins were identified with GO classifications associated with glycosylation pathways 
(GO:0006013: mannose metabolic process; GO:0006491: N-linked oligosaccharide 
processing) and the immune response (GO:0071353: Cellular response to IL-4; GO:0030593; 
Neutrophil chemotaxis; GO:0007159: Leukocyte cell-cell adhesion). 
 
All 341 proteins identified in Man-FhTeg (Supplemental Table 5-7) were analysed for the 
presence of potential glycosylation motifs.  This analysis revealed that 34 proteins had no 
putative glycosylation sites (51 when higher stringency (0.75) was applied to the N-
glycosylation predictive threshold).  Cathepsins L2 and L5, fatty acid binding protein Fh2 
and Fh3 are included among the proteins with no putative glycosylation sites. This data 
suggests that these non-glycosylated proteins could be co-eluted with mannosylated proteins 
as part of multi-molecular complexes. Interestingly, several non-glycosylated proteins 
identified in the Man-FhTeg preparation belonged to the proteosome complex (GO:0019773). 
Glycoproteins in both the Man- and Glyco-FhTeg fractions exhibit a wide variety of 
subcellular locations observed which is not surprising since the surface tegument is composed 
not only of membrane-associated proteins but also cytoplasmic, cytoskeletal and 
microtubule-associated proteins (10) (Figure 6).  
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DISCUSSION  
This study examining the glycosylation of F. hepatica surface tegument is the most extensive 
lectin-based investigation to date. Here, we found an abundance of carbohydrate motifs on 
the outer aspects of the parasite surface, while lectin fluorescence microscopy experiments, 
conducted under non-permeabilizing conditions, enabled the remarkable observation of 
intricate details of the tegumental morphology, especially spines and spinelets that are not 
often revealed in standard fluorescence micrographs. Plant lectins have been previously used 
to probe F. hepatica preparations and revealed a complex collection of exposed 
oligosaccharide structures in the tegument (27-29) but the molecular nature of these 
presentations remains enigmatic. 
 
FhTeg was comprised of a rich mixture of glycoconjugates. However, we discovered that 
most proteins are predominantly modified by oligomannose glycans that are widely 
distributed on the spines, suckers and tegumental coat of F. hepatica and lectin blot analysis 
supported the abundance of these N-glycosylated proteins. It is likely that glycoproteins on 
the tegument are modified with a mixture of N-linked oligosaccharide structures as different 
lectins tested in the analysis bound to protein bands of similar molecular size. 
Oligosaccharide structures with terminal GlcNAc and GalNAc were distributed widely on the 
anatomical features of the parasite surface, although a smaller panel of glycoproteins carrying 
these residues were identified by lectin blot. In contrast, Fuc, Gal and α(2-3)-linked sialic 
acid  residues were distributed in discrete anatomical regions only. The sialic acid-binding 
proteins MAL II and SNA-I recognised ligands predominantly located on the parasite surface, 
corroborating the previous observation of sialylated glycoproteins in the F. hepatica tegument 
(12, 29). This is of special interest as helminths are believed to lack the biosynthetic 
machinery required for sialylation and raises the possibility that FhTeg sialic acid-containing 
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oligosaccharides are derived from host glycoproteins as a form of immune defense, as also 
suggested for blood-sucking adult Ixodes ricinus ticks although we have no evidence to 
support this (30).  
          
Tegumental proteins of F. hepatica represent a very complex biological matrix, but the extent 
of its complexity has only recently become clearer due to the emergence of proteomic and 
glycomic methods, together with the availability of extensive transcriptomic and genomic 
data (29). In this study, proteomic analysis of the FhTeg, Glyco-FhTeg and Man-FhTeg 
protein fractions identified a total of 369 proteins. A small subset of host proteins were also 
identified, mainly those associated with the host blood and immune system. The 
identification of host immunoglobulins is consistent with proteomic analysis of Schistosoma 
mansoni tegument (31).  Braschi and colleagues inferred that although previous studies have 
shown that schistosomes are able to envelop themselves in host proteins, the host proteins are 
present in small concentration that are enriched during the  streptavidin affinity purification 
protocol.  The enrichment of FhTeg by lectin affinity chromatography also aided in the 
identification a greater number of F. hepatica specific-proteins across three preparations than 
the analysis of a single set alone.  And, despite these differences, they shared a similar gene 
ontology profile. Comparing the output of our proteomic study with other reports, nearly 60% 
of the proteins were identified previously using F. hepatica preparations obtained by NP-40 
extraction or freeze-thaw-vortex (4, 5, 6). In particular, when compared to the most recent 
and comprehensive proteomic study by Hacaritz et. al (2014) that identified 444 proteins, 
their analysis revealed more putative proteins isoforms with 75 additional proteins . Similarly, 
comparative analysis based on putative protein annotation, with schistosome tegument 
proteomic datasets (32,33), revealed that ~50% of the proteins overlapped with our study, 
including several proteins associated with structural and motor function, binding, kinase 
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activity and enzymatic activity.  Differences between these various studies likely reflects the 
variability between parasite isolates, methods for protein isolation and the different databases 
used for analysis of MS data. In the present study, gene models were reliably identified by 
our recently sequenced F. hepatica draft genome (4, 5, 6, 34). 
 
The surface tegument consists of a cellular syncytium covered with a glycocalyx that is 
continually replaced by highly active sub-tegumental cells that send vesicles to the surface to 
maintain its integrity and defend against host immune attack (12). Thus it can be viewed as a 
dynamic tissue and, hence, it is not surprising that several proteins of mitochondrial origin 
were identified in FhTeg and enriched in the Glyco-FhTeg and Man-FhTeg fractions, which is 
consistent with previous studies on tegumental and surface protein preparations from F. 
hepatica (5,6). The in silico prediction of N-glycosylation sites revealed the presence of 
putative N-linked glycosylation for all observed mitochondrial proteins except phosphate 
carrier protein, voltage-dependent anion-selective channel protein 2 and ATP:ADP antiporter. 
Although glycosylation of mitochondrial proteins is generally considered rare, recent studies 
have shown the presence of N-linked glycosylation in mitochondria and on proteins with 
mitochondrial functions in rats and cattle (35,36).  
 
The success of helminth parasites such as F. hepatica has been attributed to their ability to 
subvert the immune response of their host (37) and they do this by excreting and secreting a 
battery of molecules (often-termed ES products). Proteomic analysis of the ES products 
(FhES) of adult F. hepatica suggested that some molecules are released using classical 
secretory signal pathways mainly from the parasite digestive system and by non-classical 
means in the form of blebbing or the release of vesicles from the tegument (38). More 
recently, we have characterised the immune modulatory properties of F. hepatica tegument 
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demonstrating similarities to the FhES potent Th1 immune suppressive properties (13). In 
contrast, while FhES induces adaptive Th2/Treg cell responses, FhTeg induces anergenic like 
immune responses that can be reversed by the addition of IL-2 to culture (39). 
  
F. hepatica excretory-secretory products and antigens released from other helminths (40-42) 
were shown to interact with C-type-lectin receptors (CLR) pointing to the contribution of 
glycoconjugates to their immune modulatory properties. While FhTeg glycoproteins engage 
with the mannose receptor (MR) its immunomodulatory activity is retained even in the 
absence of MR, suggesting the involvement of other CLRs (43). This result was surprising 
given that FhTeg appears to include a large group of highly mannosylated proteins. While 
FhTeg activated DCs induce anergenic T-cells and MR is critical in this process we have yet 
to determine if FhTeg interaction is essential to the phenotypic development of FhTeg 
activated DCs that express high levels of MR (33). The involvement of other CLRs, such as 
DC-SIGN, MGL and Dectin-2 is most extensively studied for S. mansoni soluble egg 
antigens (44, 45) demonstrating that glycoconjugates interact with a number of CLR’s on 
innate immune cells with a synergistic effect (45). While currently, little is known about 
CLR-targeting by FhTeg it is possible given that there is a wide variety of carbohydrate 
motifs that are similar to other helminths and are involved in the fluke’s immune regulatory 
properties through the potential host recognition of parasite glycoproteins (43).  
 
The immune modulatory molecules of FhTeg have yet to be identified, however, this analysis 
revealed a number of glycoproteins that may be potential candidates some of which have not 
been previously reported. One such molecule, which was found in F. hepatica exosomes (38), 
is the receptor for tetraspanin CD63, a surface-associated membrane protein involved in 
innate immune cell activation, adhesion and differentiation (46-48). A second molecule, TRIL 
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(TLR4 interactor with leucine-rich repeats), is a recently discovered accessory protein of 
TRL4 and TLR3 signalling complexes (49, 50) that is highly expressed in tissues from 
different species (48). TRIL can bind directly to LPS (50) which could explain how FhTeg 
prevents LPS-driven responses in dendritic cells and mast cells (13, 14). 
Metalloendopeptidase nardilysin, a peptidase that was shown to be ubiquitously localized in 
several mammalian organ systems (51) is involved in TNFα shedding from immune cells 
through the binding and activation of TNFα-converting enzyme (52). It is also a putative 
shedding enzyme for VTCN-1 (V-set domain-containing T cell activation inhibitor-1), an 
inhibitory molecule of T-cell activation that has an important role in the balance between 
abnormal T-cell activation and T-cell anergy. F. hepatica nardilysin-like molecules may act as 
a decoy preventing the binding and activation of TNFα-converting enzyme or may contribute 
to T-cell imbalance leading to T-cell anergy which is associated with FhTeg (39).   
 
While FhTeg glycoproteins are highly decorated with oligosaccharides, we do not know if 
these oligosaccharides are important to the immune response during infection. Anti-
oligosaccharide antibodies are present in sera from Schistosoma infected humans, monkeys 
and mice (53, 54) and these antibodies identified a number of antigenic oligosaccharides 
including LDNF LDN and LeX that are found on the surface tegument of adult S. mansoni 
and schistosomula (55, 56). Antigenic oligosaccharides were also reported in infection with 
metacestodes, cestodes and filarial nematodes (55). These oligosaccharides can be unique to 
helminth species or structures can also be shared with plants and invertebrates making them 
viable vaccine candidates. Identification of the most potent immunogenic glycoconjugates 
could lead to the development of novel carbohydrate based vaccine candidates. F. hepatica 
mannosylated glycoproteins induced significant protection against S. mansoni infected mice 
however it is yet to be determined if the glycoconjugates are important to the development of 
Fasciola hepatica tegumental glycoproteins 
 
25 
 
immunity (57).  Similarly, Venom Allergen-like II protein (58, 59) and enolase (60, 61) which 
were also identified in worm tegument have also been posited as potential vaccine candidates. 
Consistent with preparations of FhES, several putative vaccine candidates were identified in 
our three tegumental preparations. Interestingly, cathepsin B and paramyosin were only 
identified in the Man-FhTeg preparation, which suggests that these proteins are glycosylated 
with mannose oligosaccharides.   
 
Despite the advancement of our understanding of helminth pathogens, no commercial vaccine 
is available to prevent helminth infection. ‘Barbervax’ is a multi-component complex of 
natively purified gut-derived proteins/glycoproteins of the intestinal nematode Haemonchus 
contortus (barbervax.com.au) that was recently released as a commercial vaccine. However, 
it has not been determined if the carbohydrate residues as important for immunity. In contrast 
there are a number of commercially successful carbohydrate based bacterial vaccines that are 
derived from natural and synthetic sources which utilise non-specific conjugation methods to 
carrier proteins (62).  Carbohydrate-based vaccines for helminth therefore could be a reality. 
However, the factors that inhibit the development of the vaccine are the complexity of 
helminth biology and its immune modulatory properties.  Given that F. hepatica and other 
helminth proteins are extensively coated with glycoconjugates, the failure of helminth-
derived vaccines to date may be due to the lack of effective antibody responses against these 
molecules that play such an important role in helminth biology and immune modulatory 
properties. This study reveals the complex matrix of F. hepatica tegumental proteins by 
providing novel insights regarding their putative glycosylation and the importance of this 
work is therefore raises questions to the role these glycoconjugates in host-parasite 
interactions and in glycoprotein based helminth vaccine. 
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Fig. 1. Lectin microarray reveals that Fasciola hepatica tegument (FhTeg) 
exhibits a rich and complex oligosaccharide make up. Fluorescently labelled 
FhTeg (8.6 μg ml-1) was incubated with a proprietary lectin microarray (1 h, 23 
°C, 4 rpm) in TBS-T supplemented with 1 mM Ca2+ and Mg2+. Slides were 
scanned in a microarray scanner using a 543 nm laser. Histogram represents the 
the mean fluorescence intensity of three experimental replicates (18 data points 
in total) of fluorescently labelled FhTeg binding to printed lectins. Error bars are 
the standard deviation of the mean of three experimental replicates (A). Binding 
data is also represented as a heat map and depicts both mean intensity and 
individual replicates (B) in which little to no binding intensity is represented by 
green and greatest intensity by red.  
 
Fig 2. Mannose- and fucose-rich glycoproteins are highly abundant and predominantly 
localized on scales and suckers of adult flukes. Flat fixed whole adult flukes were probed 
with fluorescein-labelled mannose, fucose and complex oligosaccharide-binding lectins 
(green) and, where displayed, with DAPI nuclear staining (blue). Lectin blots represent 
tegumental proteins (15μg), probed with mannose, fucose and complex oligosaccharide 
biotin-labelled lectins orIR-labelled streptavidin complex (green), molecular mass marker 
(red). 
 
Fig. 3. GlcNAc-rich motifs are efficiently recognised by lectin fluorescence on adult 
flukes but not by lectin blots. GlcNAc- and GalNAc-rich glycoconjugates are highly 
expressed on FhTeg as visualised in lectin fluorescence micrographs but only a few protein 
bands were recognised by lectin blots of adult Fasciola hepatica tegumental coat. Flat fixed 
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whole adult flukes were probed with fluorescein-labelled GlcNAc- and GalNAc-binding 
lectins (green) and, where displayed, with DAPI nuclear staining (blue). In lectin blots, 
tegumental proteins (15μg) were probed with GlcNAc- and GalNAc-binding biotin-labelled 
lectins or IR-labelled streptavidin complex (green), molecular mass marker (red). 
 
Fig 4. Negatively charged oligosaccharides are present on scales and suckers of adult 
flukes. Flat fixed whole adult flukes were probed with fluorescein-labelled charged and 
galactose binding lectins (green) and, where displayed, with DAPI nuclear staining (blue). In 
lectin blots, tegumental proteins (15μg) were probed with charged and galactose biotin-
labelled lectins/IR-labelled streptavidin complex (green), molecular mass marker (Red). 
 
Fig. 5. Venn diagram to demonstrate a) the number of proteins identified within the F. 
hepatica tegument (FhTeg) and the lectin enriched glycoprotein fractions of the tegument 
(Glyco-FhTeg and Man-FhTeg) and b) the number of proteins identified within the mannose 
lectin enriched glycoprotein fraction of the tegument (Man-FhTeg) 
 
Fig. 6. Comparative Gene Ontology analysis of the protein components of FhTeg, 
Glyco-FhTeg and Man-FhTeg preparations. Stacked column charts show the percentage 
distribution of proteins identified in FhTEg, GlycoFhTeg and Man-FhTeg fractions classified 
by Biological Process, Molecular Function and Cellular Compartment.  
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Table 1. Lectin origin and nominal oligosaccharide binding specificities according to CFG 
oligosaccharide array public data.  
Abbreviation Origin Binding specificity 
ConA Concanavalia ensiformis α-linked Man, branched and terminal 
LCA Lens Culinaris Core fucosylated terminal LacNAc, Man, GlcNAc 
PSA Pisum sativum Core fucosylated terminal LacNAc, Man, GlcNAc 
GNL Galanthus nivalis Man 
AAL Aleuria aurantia Fuc-α-(1,6)-GlcNAc; Fuc-α-(1,3)-Gal-β-(1,4)-GlcNAc 
UEA-I Ulex europaeus Fuc-α-(1-2)-LacNAc  
PHA-E Phaseolus vulgaris Biantennary complex N-linked glycans  
PHA-L Phaseolus vulgaris Tri- and tetra-antennary complex oligosaccharides 
sWGA  
(succinylated WGA) Triticum vulgaris GlcNAc 
Jacalin Artocarpus integrifolia GlcNAc-β-(1,3)-Gal; Gal-β-(1,3)-GalNAc-α-Thr/Ser 
WGA Triticum vulgaris  GlcNAc; Neu5Ac 
GSL-II Griffonia simplicifolia GlcNAc 
SBA Soybean Terminal GalNAc 
DBA Dolichos biflorus α-GalNAc 
VVL Vicia villosa Terminal GalNAc 
GSL-I Griffonia simplicifolia α-GalNAc ; GalNAc α-Thr/Ser; α-Gal 
MAL-II Maackia amurensis Neu5Ac-α(2,3)-Gal(NAc); sulfated glycans 
MAL-I Maackia amurensis LacNAc; Neu5Ac-α-(2,3)-Gal(NAc) 
SNA-I Sambucus nigra Neu5Ac-α-(2,6)-Gal(NAc) 
PNA Arachis hypogea Gal-β-(1,3)-GalNAc-α-Thr/Ser 
RCA120 Ricinus communis LacNAc 
ECL Erythrina cristagalli LacNAc 
Man: Mannose; LacNAc: N-acetyllactosamine; GlcNAc: N-acetylglucosamine; Fuc: Fucose; Gal: Galactose; GalNAc: N-
acetylgalactosamine; Neu5Ac: N-acetylneuraminic acid; Thr: Threonine; Ser: Serine. 
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Table 2. Summary of lectin binding on micrographs 
Lectin Spines/Spinlets Suckers 
Oral/Ventral 
Surface coat 
Mannose binding lectins 
ConA +++++ +++++ +++++ 
LCA +++++ +++++ +++++ 
PSA +++++ +++++ +++++ 
GNL +++++ +++++ +++++ 
Fucose binding Lectin 
AAL +++++   
UEA +  +++++ 
Complex-type N-Linked oligosaccharides binding lectins 
PHA-E  +++++  
PHA-L  +++++  
Terminal GlcNAc binding lectins 
S-WGA +++++ +++++ +++++ 
Jaclin +++++ +++++ +++++ 
WGA +++++ +++++ +++++ 
GSL-I +++++ +++++ +++++ 
Terminal GalNAC binding lectins 
SBA +++++ +++++ +++++ 
DBA ++ ++ ++ 
VVL ++ ++ ++ 
GSL-1 +++++ +++++ +++++ 
Terminal α2-3 sialic acids binding lectins 
MAL-II +++   
MAL-I +++   
SNA +++   
Terminal Galactose binding lectins 
PNA +++++  +++ 
RCA   +++ 
ECL +++++  +++ 
+ to ++ low intensity;  +++ medium intensity; +++++ high intensity 
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Table 3 Unique proteins identified from the GlycoFhTeg preparation annotated using 
the F. hepatica genome, grouped by Gene Ontology classification. 
Description Identifier UP 
Molecular Function: Binding (GO:0005488) 
Actin BN1106_s3541B000067 3 
Actin BN1106_s2907B000132 2 
Actin interacting protein 1 BN1106_s2434B000197 2 
Annexin BN1106_s819B000365 2 
Elongation factor 2 BN1106_s1739B000159 3 
Eukaryotic initiation factor 4A BN1106_s664B000642 4 
HSP70 BN1106_s617B000558 3 
Titin BN1106_s1119B000202 2 
Uncharacterized protein 
 
BN1106_s538B000488 3 
Molecular Function: Catalytic activity (GO:0003824) 
Alanine aminotransferase BN1106_s1834B000180 2 
Aldo-keto reductase BN1106_s1026B000549 5 
Aldose 1-epimerase BN1106_s4504B000167 2 
cAMP-dependent protein kinase  BN1106_s417B000229 2 
Dipeptidyl peptidase 3 BN1106_s13034B000002 2 
Glucan/glycogen phosphorylase BN1106_s916B000191 3 
Inorganic pyrophosphatase BN1106_s1848B000328 2 
Retinol dehydrogenase BN1106_s1383B000093 2 
Serpin BN1106_s3864B000104 2 
Tropinone reductase;3-oxoacyl-[acyl-carrier-protein] 
reductase;2-deoxy-D-gluconate 3-dehydrogenase 
BN1106_s1612B000139 2 
Ubiquitin-protein ligase BRE1 BN1106_s208B000185 4 
UTP-glucose-1-phosphate uridylyltransferase BN1106_s244B000349 3 
Zinc binding dehydrogenase;Trans-2-enoyl-CoA reductase BN1106_s4810B000086 2 
 
Biological Process: Cellular component organization/biogenesis (GO:0071840) 
Calponin BN1106_s773B000382 2 
 
Biological Process: Cellular process (GO:0009987) 
Dynein light chain BN1106_s1444B000096 2 
 
No Gene Ontology characterisation 
Uncharacterised BN1106_s263B000603 2 
Venom allergen-like (VAL) 11 protein BN1106_s1956B000118 2 
* UP – unique peptide 
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Table 4. Representation of the top proteins identified by mannose-specific lectin affinity 
chromatography, annotated using the F. hepatica genome, grouped by Gene Ontology 
classification. 
  Unique Peptide 
Description Identifier ConA LCA GNL 
Molecular Function: Binding (GO:0005488) 
Actin BN1106_s2907B000133 14 8 12 
Alpha actinin BN1106_s4069B000247 24 7 24 
Basement membrane-specific heparan 
sulfate proteoglycan core protein 
BN1106_s25B000189 11 50 33 
Calnexin BN1106_s553B000158 2 6 8 
Calreticulin BN1106_s2673B000071 9 3 6 
Filamin BN1106_s1515B000336 9 0 13 
Filamin BN1106_s296B000186 9 0 3 
Fimbrin/Plastin BN1106_s1403B000129 13 9 15 
Gelsolin/Severin BN1106_s2349B000188 11 8 12 
HSP70 BN1106_s309B000234 13 10 14 
HSP70/HSP105 BN1106_s2091B000373 9 3 16 
HSP90 BN1106_s1320B000236 7 7 12 
Myosin BN1106_s323B000258 9 11 14 
Myosin BN1106_s3182B000117 0 8 15 
Tegumental calcium binding EF hand 
protein 
BN1106_s214B000744 7 3 8 
Telomerase protein component 1 BN1106_s306B000267 10 10 10 
200kDa GPI anchored surface 
glycoprotein 
BN1106_s168B000275 5 15 16 
 
Molecular Function: Catalytic activity (GO:0003824) 
Acetate:succinate CoA transferase BN1106_s11911B000016 7 4 9 
Aldehyde dehydrogenase BN1106_s645B000322 7 0 6 
Alpha mannosidase BN1106_s666B000200 0 10 3 
Calpain BN1106_s204B000249 12 8 17 
cAMP dependent protein kinase BN1106_s2316B000078 4 0 10 
Cathepsin A (Carboxypeptidase C) BN1106_s1241B000264 5 8 7 
Cathepsin B10 BN1106_s1840B000150 4 6 5 
Cathepsin L1 BN1106_s8490B000026 7 7 7 
Cathepsin L2 BN1106_s8098B000020 12 11 12 
Cathepsin L5 BN1106_s4636B000039 8 8 7 
Enolase BN1106_s3227B000227 8 5 12 
ER calcistorin/Protein disulphide 
isomerase 
BN1106_s2763B000063 19 10 5 
Fructose bisphosphate aldolase BN1106_s4469B000065 12 10 12 
Galactosidase alpha BN1106_s1241B000260 8 10 12 
Galactosidase beta BN1106_s5248B000014 6 7 2 
Glutamate dehydrogenase BN1106_s5767B000030 10 11 12 
Glutathione dehydrogenase BN1106_s50B000678 8 3 8 
GST sigma class BN1106_s1081B000242 6 5 8 
Hexokinase A BN1106_s175B000200 5 4 9 
Lysosomal Pro X carboxypeptidase BN1106_s1620B000120 0 7 5 
Lysosomal Pro X carboxypeptidase BN1106_s3518B000132 4 8 11 
Malic enzyme BN1106_s233B000262 12 8 16 
Mut protein BN1106_s3452B000178 7 5 13 
Nardilysin BN1106_s2211B000138 7 9 23 
Paramyosin BN1106_s1922B000122 11 8 9 
Propionyl CoA carboxylase BN1106_s1551B000468 12 4 7 
Propionyl CoA carboxylase BN1106_s1252B000359 16 12 19 
Phosphatidylcholine-sterol acyltransferase BN1106_s4998B000033 3 9 6 
Phosphoenolpyruvate carboxykinase BN1106_s246B000252 13 12 19 
Protein disulphide isomerase BN1106_s4999B000041 7 7 3 
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Pyrroline 5 carboxylate reductase BN1106_s1098B000219 8 2 4 
Pyruvate carboxylase BN1106_s1091B000125 7 4 14 
Serpin BN1106_s3864B000104 5 6 5 
Serpin BN1106_s1727B000096 5 6 8 
Sulfhydryl oxidase BN1106_s207B000270 4 8 7 
Succinate dehydrogenase BN1106_s1501B000239 7 4 7 
2 oxoglutarate dehydrogenase BN1106_s425B000529 15 7 27 
14-3-3 protein BN1106_s3904B000042 5 3 9 
14-3-3 protein BN1106_s686B000273 10 8 8 
 
Molecular Function: Molecular function regulator (GO:0098772) 
Annexin BN1106_s945B000218 7 8 7 
Annexin BN1106_s819B000364 10 8 10 
Multi-domain cystatin (cys1) BN1106_s1612B000138 16 44 44 
 
Molecular Function: Structural molecule activity (GO:0005198) 
Collagen type XV alpha BN1106_s26B000447 14 18 15 
Spectrin BN1106_s2351B000181 5 12 28 
Spectrin BN1106_s4255B000066 8 18 50 
Tubulin beta-3b BN1106_s4860B000047 9 8 9 
Tubulin alpha-2 BN1106_s925B000543 5 4 9 
 
Biological Process: Biological adhesion (GO:0007155) 
Laminin BN1106_s656B000154 0 7 0 
 
Biological Process: Localization (GO:0051179) 
Restin/Dynactin 1 BN1106_s980B000151 0 6 8 
 
No Gene Ontology characterisation 
DM9 domain containing protein BN1106_s5689B000026 11 10 9 
Tropomyosin BN1106_s4130B000080 5 8 7 
Vacuolar protein sorting 26 (vps26) BN1106_s2566B000129 3 5 10 
Uncharacterised BN1106_s8038B000016 7 7 8 
Uncharacterised BN1106_s1647B000242 8 14 4 
Uncharacterised BN1106_s6006B000040 9 5 5 
Uncharacterised BN1106_s6821B000024 4 9 5 
 
 
